Jun 2026 (Q2 FY26) — Aug 6, 2026
Stoneridge Q2 FY26 — Strong Organic Growth and Operational Efficiency Gains
Read the full callStoneridge (SRI) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Stoneridge earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 181 | +15.1% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -0.7 | +2.0 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -5.3 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$5.74 −0.86% · −$0.05
Performance −12.9% 1Y
1Y: $6.59 on 17 Oct 2025 → $5.74. High $9.17 (10 Feb 2026), low $4.72 (30 Mar 2026).
- Previous close
- $5.79
- 52-week range
- $4.72 – $9.17
- One year
- −18.00%
Overview
- Symbol
- SRI
- Sector
- Consumer Discretionary
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Stoneridge earnings calls (SRI)
Financials
What the filings say
Net profit, year on year: +44% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 214 | 218 | 149 | 158 | 210 | 205 | 161 | 181 |
| Operating profit | 0 | -4 | -4 | -4 | -3 | -30 | -9 | -1 |
| Operating margin | 0.1% | −2.0% | −2.9% | −2.7% | −1.6% | −14.4% | −5.6% | −0.7% |
| Profit before tax | -4 | -6 | -6 | -10 | -10 | -31 | -13 | -3 |
| Tax rate | −93.3% | 1.0% | −24.5% | −16.1% | 3.5% | −148.2% | −10.6% | −93.9% |
| Net profit | -7 | -6 | -7 | -9 | -9 | -77 | -28 | -5 |
| EPS ($ per share) | -0.26 | — | -0.26 | -0.34 | -0.34 | — | -1 | -0.19 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | — | — | — | 0 | 0 | 0 | 0 | 0 |
| Reserves | 146 | 207 | 212 | 216 | 202 | 197 | 180 | 77 |
| Total liabilities | 276 | 312 | 325 | 369 | 371 | 392 | 376 | 371 |
| Fixed assets | 112 | 122 | 119 | 108 | 105 | 110 | 98 | 63 |
| Total assets | 560 | 602 | 621 | 665 | 652 | 680 | 622 | 551 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 81 | 25 | 29 | -36 | 7 | 5 | 48 | 34 |
| Cash from investing | -28 | -6 | -34 | 28 | -29 | -37 | -24 | -22 |
| Cash from financing | -34 | -28 | 7 | 23 | -7 | 17 | 11 | -25 |
| Net cash flow | 15 | -12 | 5 | 12 | -31 | -14 | 31 | -6 |
| Capital expenditure | -29 | -36 | -28 | -23 | -27 | -38 | -24 | -22 |
| Free cash flow | 52 | -11 | 1 | -59 | -20 | -34 | 23 | 12 |
Insider filings
27 filings between Mar 2, 2026 and Sep 9, 2026.
Open market
decisions to buy or sellPurchases
$153.6K
4 purchases by 4 insiders
Sales
$68.0K
1 sale by 1 insider
Compensation
not trading decisions- 7
- Award — granted as compensation
- 8
- Option exercise — converted options into shares
- 6
- Tax withheld — shares kept back by the company to cover tax
Also filed: 1 disposition to issuer.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Ferraiolo Caetano Roberto | — | $68.0K | Jun 15, 2026 |
| Humphrey Scott Randall | $42.1K | — | Aug 18, 2026 |
| Kaplan Ira C. | $37.7K | — | Jun 3, 2026 |
| LASKY WILLIAM M | $37.3K | — | Jun 12, 2026 |
| Noblet Natalia | $36.5K | — | Aug 10, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 9, 2026 | Noblet Natalia President and CEO | Option exercise | 12,264 | $0 |
| Aug 18, 2026 | Humphrey Scott Randall CFO and Treasurer | Purchase | 6,000 | $42.1K |
| Aug 10, 2026 | Noblet Natalia President and CEO | Purchase | 5,000 | $36.5K |
| Jun 15, 2026 | Ferraiolo Caetano Roberto President Stoneridge Brazil | Sale | 9,000 | $68.0K |
| Jun 12, 2026 | LASKY WILLIAM M Director | Purchase | 5,000 | $37.3K |
| Jun 3, 2026 | Kaplan Ira C. Director | Purchase | 5,000 | $37.7K |
| May 20, 2026 | Zizelman James President and CEO | Tax withheld | 169,465 | $1.17M |
| May 20, 2026 | Zizelman James President and CEO | Option exercise | 142,933 | — |
| May 20, 2026 | Zizelman James President and CEO | Disposition to issuer | 142,933 | $984.8K |
| May 20, 2026 | Zizelman James President and CEO | Option exercise | 430,663 | $0 |
| Mar 16, 2026 | Korth Kim Director | Award | 23,478 | $0 |
| Mar 16, 2026 | LASKY WILLIAM M Director | Award | 23,478 | $0 |
| Mar 16, 2026 | Sklarsky Frank S Director | Award | 23,478 | $0 |
| Mar 16, 2026 | Rutt Sheila M Director | Award | 23,478 | $0 |
| Mar 16, 2026 | Reinhardt Carsten J Director | Award | 23,478 | $0 |
| Mar 16, 2026 | Kaplan Ira C. Director | Award | 23,478 | $0 |
| Mar 16, 2026 | English Aron R. Director | Award | 23,478 | $0 |
| Mar 2, 2026 | Hartman Robert J. Jr. Chief Accounting Officer | Tax withheld | 1,063 | $8.2K |
| Mar 2, 2026 | Hartman Robert J. Jr. Chief Accounting Officer | Option exercise | 3,148 | $0 |
| Mar 2, 2026 | Ferraiolo Caetano Roberto President Stoneridge Brazil | Option exercise | 4,961 | $0 |
| Mar 2, 2026 | Ferraiolo Caetano Roberto President Stoneridge Brazil | Tax withheld | 1,337 | $10.3K |
| Mar 2, 2026 | Benedict Susan C. CHRO and Assistant GC | Option exercise | 7,396 | $0 |
| Mar 2, 2026 | Benedict Susan C. CHRO and Assistant GC | Tax withheld | 3,224 | $24.8K |
| Mar 2, 2026 | Zizelman James President and CEO | Option exercise | 19,363 | $0 |
| Mar 2, 2026 | Zizelman James President and CEO | Tax withheld | 7,619 | $58.6K |
| Mar 2, 2026 | Horvath Matthew R. Chief Financial Officer | Option exercise | 9,052 | $0 |
| Mar 2, 2026 | Horvath Matthew R. Chief Financial Officer | Tax withheld | 3,946 | $30.3K |
| Jun 20, 2025 | Ferraiolo Caetano Roberto President Stoneridge Brazil | Option exercise | 14,551 | — |
| Jun 20, 2025 | Ferraiolo Caetano Roberto President Stoneridge Brazil | Disposition to issuer | 14,551 | $81.6K |
| Jun 20, 2025 | Cooprider Troy Chief Technology Officer | Option exercise | 11,641 | — |
| Jun 20, 2025 | Cooprider Troy Chief Technology Officer | Disposition to issuer | 11,641 | $65.3K |
| Jun 20, 2025 | Kased Rajaey President Control Devices | Option exercise | 14,551 | — |
| Jun 20, 2025 | Kased Rajaey President Control Devices | Disposition to issuer | 14,551 | $81.6K |
| Jun 20, 2025 | Benedict Susan C. CHRO and Assistant GC | Option exercise | 29,103 | — |
| Jun 20, 2025 | Benedict Susan C. CHRO and Assistant GC | Disposition to issuer | 29,103 | $163.3K |
| Jun 20, 2025 | Horvath Matthew R. Chief Financial Officer | Option exercise | 29,103 | — |
| Jun 20, 2025 | Horvath Matthew R. Chief Financial Officer | Disposition to issuer | 29,103 | $163.3K |
| May 13, 2025 | LASKY WILLIAM M Director | Award | 16,194 | $0 |
| May 13, 2025 | Kaplan Ira C. Director | Award | 16,194 | $0 |
| May 13, 2025 | Sklarsky Frank S Director | Award | 16,194 | $0 |
| May 13, 2025 | Rutt Sheila M Director | Award | 16,194 | $0 |
| May 13, 2025 | Reinhardt Carsten J Director | Award | 16,194 | $0 |
| May 13, 2025 | Korth Kim Director | Award | 16,194 | $0 |
| Mar 10, 2025 | Kaplan Ira C. Director | Award | 10,000 | $0 |
| Mar 10, 2025 | Korth Kim Director | Award | 10,000 | $0 |
| Mar 10, 2025 | Rutt Sheila M Director | Award | 10,000 | $0 |
| Mar 10, 2025 | Schlather Paul J. Director | Award | 10,000 | $0 |
| Mar 10, 2025 | Sklarsky Frank S Director | Award | 10,000 | $0 |
| Mar 10, 2025 | Mayes George S JR Director | Award | 10,000 | $0 |
| Mar 10, 2025 | LASKY WILLIAM M Director | Award | 10,000 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for STONERIDGE INC
Free account. Everything above stays public.
Write why you follow STONERIDGE INC and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading